Dividend investors are always on the lookout for stable, resilient companies that can deliver consistent income while providing a degree of capital appreciation over the long term. The Clorox Company (NYSE: CLX) has long been a popular choice for dividend-focused portfolios, given its strong history of payouts, brand recognition, and consumer staples business model. However, with recent financial challenges and a relatively high payout ratio, investors must carefully analyze whether CLX still fits the bill as a reliable dividend stock.
Company Overview
Clorox is a household name, best known for its cleaning and disinfecting products, but its product portfolio extends into other consumer goods categories such as food, personal care, and pet supplies. As a consumer staples company, Clorox has historically benefited from stable demand and pricing power, especially during periods of economic downturns. However, recent financial metrics indicate that the company is navigating a period of volatility, making it essential to examine its fundamentals from a dividend investor’s perspective.
Dividend Analysis: Is Clorox a Strong Payout Stock?
Dividend Yield and Growth
One of the primary reasons dividend investors have historically favored Clorox is its attractive dividend yield. Currently, Clorox offers a forward annual dividend of $4.88 per share, translating to a dividend yield of 3.12%. This is slightly above the company’s five-year average dividend yield of 2.88%, indicating that the stock may be trading at a more attractive valuation compared to historical levels.
However, the company’s payout ratio of 131.88% raises concerns. A payout ratio above 100% suggests that Clorox is currently paying out more in dividends than it earns in net income, which is not a sustainable practice in the long term. This is a red flag for dividend investors because it suggests potential difficulty in maintaining the current dividend level without improvements in earnings.
Dividend Growth Track Record
Clorox has an impressive history of dividend increases, which is a strong point for long-term income investors. The company has raised its dividend consistently over the years, making it part of the esteemed dividend aristocrats club. However, given the high payout ratio, investors must question whether this growth is sustainable moving forward.
Key Dates for Dividend Investors:
- Next Dividend Payment Date: May 9, 2025
- Ex-Dividend Date: April 23, 2025
For those seeking income, Clorox’s dividend schedule provides predictable quarterly payouts, but its ability to sustain and grow dividends remains a critical concern.
Financial Health and Stability: A Closer Look
Revenue and Earnings Trends
While Clorox enjoys a stable revenue base, its most recent earnings reports highlight challenges. The company reported trailing twelve-month (TTM) revenue of $7.17 billion, but quarterly revenue declined by 15.3% year-over-year, signaling potential demand softness or pricing pressures.
Despite the revenue decline, quarterly earnings growth soared by 107.5% year-over-year, suggesting that cost-cutting initiatives and operational efficiencies have played a role in boosting profitability. However, whether this improvement is sustainable remains to be seen.
Profitability Metrics
- Profit Margin: 6.38%
- Operating Margin (TTM): 13.88%
- Return on Assets (ROA): 11.27%
- Return on Equity (ROE): 276.11% (inflated due to high debt levels)
Clorox’s profit margins remain stable, but one of the biggest concerns is its debt levels relative to equity.
Debt and Liquidity
One of the most alarming aspects of Clorox’s financial position is its high debt-to-equity ratio of 2,555.37%. This indicates that the company is highly leveraged, which can be risky, particularly in a rising interest rate environment. Clorox carries $3.09 billion in total debt, with only $290 million in cash, leading to a relatively weak current ratio of 0.94.
This means that Clorox may face liquidity challenges, particularly if revenue continues to decline or if it struggles to maintain profitability. Dividend investors should be mindful that high debt levels can sometimes lead companies to cut dividends in order to free up cash for debt servicing.
Valuation and Market Performance
Price-to-Earnings (P/E) Ratios
- Trailing P/E: 42.61 (elevated relative to historical norms)
- Forward P/E: 22.88 (more reasonable but still above peers)
- PEG Ratio (5-year expected): 0.72 (suggests decent growth potential)
Clorox’s trailing P/E of 42.61 is high, indicating that investors are still willing to pay a premium for its defensive business model despite recent financial struggles. However, its forward P/E of 22.88 suggests that analysts expect earnings to improve, which could support the current valuation.
Stock Performance and Beta
- 52-Week Range: $127.60 – $171.37
- Current Price: $155.48
- 50-Day Moving Average: $157.34
- 200-Day Moving Average: $152.25
- Beta (5Y Monthly): 0.44
Clorox has been trading within a relatively stable range, and its low beta of 0.44 suggests it is less volatile than the broader market. This is a positive trait for conservative dividend investors, as lower volatility means fewer price swings that could impact portfolio stability.
Chart Analysis
CLX has had an interesting journey over the past year, showing a strong recovery phase followed by some recent turbulence. The stock rallied impressively through the middle of last year, breaking above both its 50-day and 200-day moving averages, signaling bullish momentum. However, after reaching its peak around December, it started to roll over, with the 50-day moving average beginning to turn downward. This suggests that short-term momentum has weakened. Recently, the price dipped below the 50-day MA and briefly tested the 200-day MA as support before bouncing back up. That kind of reaction off a long-term moving average is often a sign that institutional investors see value at those levels, making it a key area to watch in the coming weeks.
Volume has been a mixed bag, with some larger red spikes in February that indicate bouts of selling pressure. However, the fact that the price found support near the 200-day MA and has started to stabilize suggests that sellers may be running out of steam. The RSI hovering around 52 is another sign of neutrality, meaning the stock isn’t in an extreme position in either direction. The last few candles have shown some hesitation, with wicks on both ends, which suggests buyers and sellers are in a bit of a standoff. If CLX can regain its footing above the 50-day moving average with strong volume, it could signal a return to bullish momentum. Otherwise, a failure to hold the 200-day moving average could mean more downside before finding stronger support.
Analyst Ratings
In recent months, The Clorox Company (CLX) has experienced a series of analyst upgrades and downgrades, reflecting diverse perspectives on its financial health and market position. As of February 5, 2025, the consensus price target among analysts stands at $160.67, suggesting a modest upside from current levels.
Upgrades:
- Wells Fargo upgraded Clorox from “Underweight” to “Equal Weight” on January 7, 2025, adjusting the price target to $157. This upgrade was attributed to Clorox’s improved operational efficiencies and cost management strategies, which are expected to enhance profitability.
- TD Cowen raised its rating from “Sell” to “Hold” on November 6, 2024, increasing the price target from $155 to $170. The firm acknowledged Clorox’s resilience in a challenging market and its efforts to stabilize revenue streams.
Downgrades:
- CFRA downgraded Clorox from “Buy” to “Hold” on October 31, 2024, setting a price target of $175. The downgrade was due to concerns over Clorox’s high debt-to-equity ratio and its potential impact on future earnings.
- Barclays maintained an “Underweight” rating on February 5, 2025, with a price target of $140. The firm cited ongoing challenges in Clorox’s core markets and a decline in consumer demand as reasons for the cautious stance.
These mixed analyst opinions highlight the complexities surrounding Clorox’s current financial situation, with considerations about operational improvements balanced against concerns over debt levels and market dynamics.
Key Risks and Considerations for Dividend Investors
While Clorox remains a well-known dividend payer, there are some risks that dividend investors should consider:
- High Payout Ratio – At 131.88%, Clorox is paying out more than it earns, which is unsustainable long term.
- Revenue Declines – A 15.3% YoY drop in revenue raises concerns about long-term growth and pricing power.
- High Debt Levels – A debt-to-equity ratio of over 2,500% is a major red flag, especially in an era of higher interest rates.
- Dividend Cut Risk – If earnings do not improve, Clorox may be forced to reduce its dividend to maintain financial stability.
- Valuation Concerns – Despite recent earnings growth, the stock trades at a higher-than-average P/E ratio, meaning it may not be a bargain.
Final Thoughts: Is Clorox Still a Strong Dividend Stock?
Clorox has long been a dividend favorite, and it still offers an attractive 3.12% dividend yield along with a strong brand and stable market position. However, the combination of high debt, a stretched payout ratio, and declining revenue presents risks that dividend investors should not ignore.
If Clorox can stabilize its revenue and improve profitability while reducing debt, it could remain a reliable dividend stock for the long haul. However, the current high payout ratio and leverage raise concerns about the sustainability of its dividend payments in the future.
For conservative income investors, Clorox may still be worth considering, but it’s essential to monitor earnings reports and debt levels closely. Those with a lower risk tolerance may prefer to wait for clearer signs of financial stabilization before committing further capital to the stock.